Tiotropium bromide - Open Access .click

Results 231 to 240 of about 5,292 (260)

Some of the next articles are maybe not open access.

Tiotropium bromide: Efficacy and safety in complex treatment of COPD

Airway Pharmacology and Treatment, 2017
Background: Chronic obstructive pulmonary disease (COPD) is a progressive disease and associated with increased morbidity and mortality. Tiotropium bromide, a anticholinergic, is a long-acting bronchodilator with a well-established effectiveness for treating COPD. But some effects of the drug remains poorly understood.
Oleksandr Varunkiv +4 more
openaire +2 more sources

Tiotropium Bromide/Olodaterol as Maintenance Treatment for Patients with COPD

Clinical Medicine Reviews in Vascular Health, 2016
Chronic obstructive pulmonary disease (COPD) requires appropriate treatment regimens, since it is a major cause of morbidity and mortality worldwide. Recently, several clinical trials confirmed that compared with tiotropium monotherapy and combination therapy of long-acting β2 agonist (LABA) plus inhaled corticosteroids (ICSs), maintenance therapy with
Kumiko Niituma +9 more
openaire +2 more sources

Protective Effects of Tiotropium Bromide in the Progression of Airway Smooth Muscle Remodeling

American Journal of Respiratory and Critical Care Medicine, 2005
Recent findings have demonstrated that muscarinic M(3) receptor stimulation enhances airway smooth muscle proliferation to peptide growth factors in vitro. Because both peptide growth factor expression and acetylcholine release are known to be augmented in allergic airway inflammation, it is possible that anticholinergics protect against allergen ...
Reinoud Gosens +3 more
openaire +4 more sources

Spin‐Dependent Charge Transport in 1D Chiral Hybrid Lead‐Bromide Perovskite with High Stability

Advanced Functional Materials, 2021
Cheng Song, Feng Pan, Hui Cao
exaly

Photosensitive Lichenoid Eruption and Inhaled Tiotropium Bromide